ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,431.60
      -0.04%
      US Tech 100
      19,168.00
      0.52%
      Dow Jones
      38,589.16
      -0.15%
      Brent Oil
      82.275
      0.00%
      Bitcoin
      66,230.29
      0.06%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Emergent Biosolutions Inc (EBS)

      7. Emergent Biosolutions Inc (EBS) News

      EBS

      Emergent Biosolutions (EBS)

      Emergent Biosolutions Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:EBS
      DateTimeSourceHeadlineSymbolCompany
      06/11/20244:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      06/11/20244:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      06/11/20244:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      06/11/20244:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      06/06/20244:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      06/06/20249:02AMGlobeNewswire Inc.Emergent BioSolutions Continues Driving Progress Against the Opioid Epidemic & Recognizes National Naloxone Awareness DayNYSE:EBSEmergent Biosolutions Inc
      06/04/20244:19PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:EBSEmergent Biosolutions Inc
      05/31/20243:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      05/29/20247:34AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
      05/28/20249:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      05/28/20249:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      05/28/20249:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      05/28/20249:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      05/28/20249:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      05/28/20249:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      05/28/20249:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      05/23/20245:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      05/10/20247:17AMGlobeNewswire Inc.Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024NYSE:EBSEmergent Biosolutions Inc
      05/01/20244:57PMGlobeNewswire Inc.Emergent BioSolutions Reports First Quarter 2024 Financial ResultsNYSE:EBSEmergent Biosolutions Inc
      05/01/20244:10PMGlobeNewswire Inc.Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial PositionNYSE:EBSEmergent Biosolutions Inc
      05/01/202411:03AMGlobeNewswire Inc.Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to NaloxoneNYSE:EBSEmergent Biosolutions Inc
      04/30/20245:26PMGlobeNewswire Inc.Emergent BioSolutions Announces Amendment to its Existing Credit FacilityNYSE:EBSEmergent Biosolutions Inc
      04/22/20248:05AMGlobeNewswire Inc.Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024NYSE:EBSEmergent Biosolutions Inc
      04/01/20248:00AMGlobeNewswire Inc.Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech ExecutiveNYSE:EBSEmergent Biosolutions Inc
      03/28/20248:15AMGlobeNewswire Inc.Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid CrisisNYSE:EBSEmergent Biosolutions Inc
      03/25/20248:05AMGlobeNewswire Inc.Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing FacilityNYSE:EBSEmergent Biosolutions Inc
      03/08/20244:21PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:EBSEmergent Biosolutions Inc
      03/07/20248:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      03/06/20244:31PMGlobeNewswire Inc.Emergent BioSolutions Reports Fourth Quarter 2023 Financial ResultsNYSE:EBSEmergent Biosolutions Inc
      03/06/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
       Showing the most relevant articles for your search:NYSE:EBS